journal article·2023-08-23Open access

Lipid–Polymer Hybrid Nanosystems: A Rational Fusion for Advanced Therapeutic Delivery

Shweta Jain, Mudit Kumar, Pushpendra Kumar, Jyoti Verma, Jessica M. Rosenholm, Kuldeep K. Bansal, Ankur Vaidya

Abstract

Lipid nanoparticles (LNPs) are spherical vesicles composed of ionizable lipids that are neutral at physiological pH. Despite their benefits, unmodified LNP drug delivery systems have substantial drawbacks, including a lack of targeted selectivity, a short blood circulation period, and in vivo instability. lipid–polymer hybrid nanoparticles (LPHNPs) are the next generation of nanoparticles, having the combined benefits of polymeric nanoparticles and liposomes. LPHNPs are being prepared from both natural and synthetic polymers with various techniques, including one- or two-step methods, emulsification solvent evaporation (ESE) method, and the nanoprecipitation method. Varieties of LPHNPs, including monolithic hybrid nanoparticles, core–shell nanoparticles, hollow core–shell nanoparticles, biomimetic lipid–polymer hybrid nanoparticles, and polymer-caged liposomes, have been investigated for various drug delivery applications. However, core–shell nanoparticles having a polymeric core surrounded by a highly biocompatible lipid shell are the most commonly explored LPHNPs for the treatment of various diseases. In this review, we will shed light on the composition, methods of preparation, classification, surface functionalization, release mechanism, advantages and disadvantages, patents, and clinical trials of LPHNPs, with an emphasis on core–shell-structured LPHNPs.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Sir Madan Lal Institute of Pharmacy, Etawah 206310, India

Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Saifai, Etawah 206130, India

Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, 20520 Turku, Finland

Funding

Business Finland

References (100+)

Show source-provided references
1. Mishra, V., Bansal, K.K., Verma, A., Yadav, N., Thakur, S., Sudhakar, K., and Rosenholm, J.M. (2018). Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems. Pharmaceutics, 10.10.3390/pharmaceutics10040191 ↗
2. Nakmode, D., Bhavana, V., Thakor, P., Madan, J., Singh, P.K., Singh, S.B., Rosenholm, J.M., Bansal, K.K., and Mehra, N.K. (2022). Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development. Pharmaceutics, 14.10.3390/pharmaceutics14040831 ↗
3. Hydrogels as Promising Therapeutic Strategy for the Treatment of Skin Cancer10.1016/j.molstruc.2022.133014 ↗
4. Synthetic Polymers from Renewable Feedstocks: An Alternative to Fossil-Based Materials in Biomedical Applications10.4155/tde-2020-0033 ↗
5. New Biomaterials from Renewable Resources—Amphiphilic Block Copolymers from δ-Decalactone10.1039/C5PY01203A ↗
6. Bansal, K., Sasso, L., Makwana, H., Awwad, S., Brocchini, S., and Alexander, C. (2017). Nanopharmacy: Exploratory Methods for Polymeric Materials, John Wiley & Sons: Wiley-VCH Verlag GmbH & Co. KGaA.10.1002/9783527800681.ch10 ↗
7. Ethyl Cellulose Coated Chitosan Microspheres of Metronidazole as Potential Anti-Amoebic Agent10.1166/jbns.2017.1483 ↗
8. Pectin–Metronidazole Prodrug Bearing Microspheres for Colon Targeting10.1016/j.jscs.2012.03.001 ↗
9. Lipid Nanoparticles for Drug Delivery10.1002/anbr.202100109 ↗
10. Attama, A.A., Momoh, M.A., Builders, P.F., Attama, A.A., Momoh, M.A., and Builders, P.F. (2012). Recent Advances in Novel Drug Carrier Systems, IntechOpen.
11. Lipid Nanoparticles─From Liposomes to MRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement10.1021/acsnano.1c04996 ↗
12. Beyond Liposomes: Recent Advances on Lipid Based Nanostructures for Poorly Soluble/Poorly Permeable Drug Delivery10.1016/j.plipres.2017.07.001 ↗
13. Grumezescu, A.M. (2019). Nanoarchitectonics in Biomedicine, William Andrew Publishing.
14. Nanoparticles and Organized Lipid Assemblies: From Interaction to Design of Hybrid Soft Devices10.1039/C9SM01601E ↗
15. Lipid Polymer Hybrid Nanoparticles: A Novel Approach for Drug Delivery (2023, August 09). IntechOpen. Available online: https://www.intechopen.com/chapters/69735.
16. Lipid-Polymer Hybrid Nanoparticles for Topical Drug Delivery System10.22270/jddt.v13i4.5789 ↗
17. Highlights on Cell-Penetrating Peptides and Polymer-Lipid Hybrid Nanoparticle: Overview and Therapeutic Applications for Targeted Anticancer Therapy10.1208/s12249-023-02576-x ↗
18. Lipid Polymeric Hybrid Nanoparticles: Formulation Techniques and Effects on Glioblastoma
19. Lipid–Polymer Hybrid Nanoparticles as a next-Generation Drug Delivery Platform: State of the Art, Emerging Technologies, and Perspectives10.2147/IJN.S198353 ↗
20. Design of Lipid-Polymer Hybrid Nanoparticles for Therapy of BPH: Part I. Formulation Optimization Using a Design of Experiment Approach10.1016/j.jddst.2017.02.012 ↗
21. Design and Development of Lipid Polymer Hybrid Nanoparticles for Combinatorial Drug Delivery
22. Screening Strategies for Surface Modification of Lipid-Polymer Hybrid Nanoparticles10.1016/j.ijpharm.2022.121973 ↗
23. Herringbone-Patterned 3D-Printed Devices as Alternatives to Microfluidics for Reproducible Production of Lipid Polymer Hybrid Nanoparticles10.1021/acsomega.9b00128 ↗
24. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy10.2147/IJN.S209325 ↗
25. Folic Acid Conjugated Nanoparticles of Mixed Lipid Monolayer Shell and Biodegradable Polymer Core for Targeted Delivery of Docetaxel10.1016/j.biomaterials.2009.09.036 ↗
26. Core Shell Lipid-Polymer Hybrid Nanoparticles with Combined Docetaxel and Molecular Targeted Therapy for the Treatment of Metastatic Prostate Cancer10.1038/s41598-017-06142-x ↗
27. Engineering of Lipid-Coated PLGA Nanoparticles with a Tunable Payload of Diagnostically Active Nanocrystals for Medical Imaging10.1039/c2cc32149a ↗
28. Immunopolymer Lipid Nanoparticles for Delivery of Macromolecules to Antigen-Expressing Cells10.1021/acsabm.0c00857 ↗
29. In Vitro and in Vivo Effect of Hyaluronic Acid Modified, Doxorubicin and Gallic Acid Co-Delivered Lipid-Polymeric Hybrid Nano-System for Leukemia Therapy10.2147/DDDT.S202818 ↗
30. Chitosan Based Polymer-Lipid Hybrid Nanoparticles for Oral Delivery of Enoxaparin10.1016/j.ijpharm.2018.05.076 ↗
31. Design of Experiment Approach Based Formulation Optimization of Berberine Loaded Solid Lipid Nanoparticle for Antihyperlipidemic Activity
32. Nanocomplexes Based on Amphiphilic Hyaluronic Acid Derivative and Polyethylene Glycol–Lipid for Ginsenoside Rg3 Delivery10.1002/jps.24111 ↗
33. Microfluidic-Based Holonomic Constraints of SiRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery10.1021/acsami.9b22781 ↗
34. Synthesis and Characterization of Curcumin Loaded Polymer/Lipid Based Nanoparticles and Evaluation of Their Antitumor Effects on MCF-7 Cells10.1016/j.bbagen.2014.01.016 ↗
35. Development and Evaluation of Isradipine via Rutin-Loaded Coated Solid-Lipid Nanoparticles
36. Core-Shell Type Lipid/RPAA-Chol Polymer Hybrid Nanoparticles for in Vivo SiRNA Delivery10.1016/j.biomaterials.2013.11.046 ↗
37. ChemoRad Nanoparticles: A Novel Multifunctional Nanoparticle Platform for Targeted Delivery of Concurrent Chemoradiation10.2217/nnm.10.6 ↗
38. Immunocompatibility Properties of Lipid–Polymer Hybrid Nanoparticles with Heterogeneous Surface Functional Groups10.1016/j.biomaterials.2009.01.005 ↗
39. Lipid-Polymer Hybrid Nanoparticles: Development & Statistical Optimization of Norfloxacin for Topical Drug Delivery System10.1016/j.bioactmat.2017.07.002 ↗
40. Single-Step Assembly of Homogenous Lipid-Polymeric and Lipid-Quantum Dot Nanoparticles Enabled by Microfluidic Rapid Mixing10.1021/nn901433u ↗
41. Physicochemical and Interfacial Investigation of Lipid/Polymer Particle Assemblies10.1021/la047659t ↗
42. Steric Stabilization of Lipid/Polymer Particle Assemblies by Poly(Ethylene Glycol)-Lipids10.1021/bm700753q ↗
43. The Comparison of Protein-Entrapped Liposomes and Lipoparticles: Preparation, Characterization, and Efficacy of Cellular Uptake10.2147/IJN.S25646 ↗
44. Core–Shell-Type Lipid–Polymer Hybrid Nanoparticles as a Drug Delivery Platform10.1016/j.nano.2012.11.010 ↗
45. General Overview of Lipid-Polymer Hybrid Nanoparticles, Dendrimers, Micelles, Liposomes, Spongosomes and Cubosomes10.1080/1061186X.2017.1367006 ↗
46. Lipid Polymer Hybrid Nanocarriers: Insights into Synthesis Aspects, Characterization, Release Mechanisms, Surface Functionalization and Potential Implications10.1016/j.colcom.2021.100570 ↗
47. Self-Assembled Lipid-Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform10.1021/nn800275r ↗
48. Lipid-Coated Polymeric Nanoparticles for Cancer Drug Delivery10.1039/C4BM00427B ↗
49. Lipid-Polymer Hybrid Nanoparticles: Synthesis Strategies and Biomedical Applications10.1016/j.mimet.2019.03.017 ↗
50. Single-Step Assembly of Cationic Lipid–Polymer Hybrid Nanoparticles for Systemic Delivery of SiRNA10.1021/nn300500u ↗
51. Two-Component Reduction-Sensitive Lipid–Polymer Hybrid Nanoparticles for Triggered Drug Release and Enhanced in Vitro and in Vivo Anti-Tumor Efficacy10.1039/C6BM00662K ↗
52. Antitumor Activity of Gemcitabine Hydrochloride Loaded Lipid Polymer Hybrid Nanoparticles (LPHNs): In Vitro and in Vivo10.1016/j.ijpharm.2020.119246 ↗
53. Double Emulsion Solvent Evaporation Techniques Used for Drug Encapsulation10.1016/j.ijpharm.2015.10.057 ↗
54. Comparison of Microencapsulation by Emulsion-Solvent Extraction/Evaporation Technique Using Derivatives Cellulose and Acrylate-Methacrylate Copolymer as Carriers
55. Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications10.1615/CritRevTherDrugCarrierSyst.2018024751 ↗
56. Synergistic Combination Therapy of Lung Cancer Using Paclitaxel- and Triptolide-Coloaded Lipid–Polymer Hybrid Nanoparticles10.2147/DDDT.S172199 ↗
57. Cholesterol-Modified Poly(Lactide-Co-Glycolide) Nanoparticles for Tumor-Targeted Drug Delivery10.1016/j.ijpharm.2016.06.008 ↗
58. Transferrin-Conjugated Lipid-Coated PLGA Nanoparticles for Targeted Delivery of Aromatase Inhibitor 7alpha-APTADD to Breast Cancer Cells10.1016/j.ijpharm.2010.02.008 ↗
59. Combinatorial Drug Conjugation Enables Nanoparticle Dual-Drug Delivery10.1002/smll.201000631 ↗
60. In Vivo Prevention of Arterial Restenosis with Paclitaxel-Encapsulated Targeted Lipid-Polymeric Nanoparticles10.1073/pnas.1115945108 ↗
61. Ultra-Small Lipid–Polymer Hybrid Nanoparticles for Tumor-Penetrating Drug Delivery10.1039/C6NR04091H ↗
62. Differentially Charged Hollow Core/Shell Lipid-Polymer-Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery10.1002/anie.201101554 ↗
63. Paclitaxel Loaded Folic Acid Targeted Nanoparticles of Mixed Lipid-Shell and Polymer-Core: In Vitro and in Vivo Evaluation10.1016/j.ejpb.2012.03.004 ↗
64. Nanoparticle Biointerfacing by Platelet Membrane Cloaking10.1038/nature15373 ↗
65. Lipid Polymer Hybrid Nanospheres Encapsulating Antiproliferative Agents for Stent Applications10.1016/j.jiec.2016.02.015 ↗
66. Influence of Cationic Lipid Concentration on Properties of Lipid-Polymer Hybrid Nanospheres for Gene Delivery
67. Erythrocyte Membrane-Cloaked Polymeric Nanoparticles for Controlled Drug Loading and Release10.2217/nnm.12.153 ↗
68. Engineering the Lipid Layer of Lipid–PLGA Hybrid Nanoparticles for Enhanced in Vitro Cellular Uptake and Improved Stability10.1016/j.actbio.2015.09.032 ↗
69. Temporal Targeting of Tumour Cells and Neovasculature with a Nanoscale Delivery System10.1038/nature03794 ↗
70. Folate-Containing Reduction-Sensitive Lipid-Polymer Hybrid Nanoparticles for Targeted Delivery of Doxorubicin10.1039/C4BM00462K ↗
71. Folate-Modified, Indocyanine Green-Loaded Lipid-Polymer Hybrid Nanoparticles for Targeted Delivery of Cisplatin10.1080/09205063.2017.1296347 ↗
72. Lipid-Polymer Nanoparticles for Folate-Receptor Targeting Delivery of Doxorubicin10.1166/jnn.2015.9604 ↗
73. Targeted Delivery of 10-Hydroxycamptothecin to Human Breast Cancers by Cyclic RGD-Modified Lipid-Polymer Hybrid Nanoparticles10.1088/1748-6041/8/2/025012 ↗
74. IRGD-Modified Lipid-Polymer Hybrid Nanoparticles Loaded with Isoliquiritigenin to Enhance Anti-Breast Cancer Effect and Tumor-Targeting Ability10.2147/IJN.S134148 ↗
75. Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme10.1166/jbn.2015.1965 ↗
76. Delivery of Multiple SiRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer10.1021/nl2035354 ↗
77. Lipid-Polymer Nanoparticles Encapsulating Curcumin for Modulating the Vascular Deposition of Breast Cancer Cells10.1016/j.nano.2014.02.004 ↗
78. Lipid–Polymer Nanoparticles Encapsulating Doxorubicin and 2′-Deoxy-5-Azacytidine Enhance the Sensitivity of Cancer Cells to Chemical Therapeutics10.1021/mp300675c ↗
79. RGD Peptide-Modified, Paclitaxel Prodrug-Based, Dual-Drugs Loaded, and Redox-Sensitive Lipid-Polymer Nanoparticles for the Enhanced Lung Cancer Therapy10.1016/j.biopha.2018.06.137 ↗
80. Lipid-Polymer Hybrid Nanoparticles Carrying Linezolid Improve Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Harbored inside Bone Cells and Biofilms10.1016/j.ejpb.2020.04.010 ↗
81. Encapsulation of Cucurbitacin B into Lipid Polymer Hybrid Nanocarriers Induced Apoptosis of MDAMB231 Cells through PARP Cleavage10.1016/j.ijpharm.2020.119565 ↗
82. Cartilage-Targeting Ultrasmall Lipid-Polymer Hybrid Nanoparticles for the Prevention of Cartilage Degradation10.1002/btm2.10187 ↗
83. Overcoming Doxorubicin Resistance with Lipid–Polymer Hybrid Nanoparticles Photoreleasing Nitric Oxide10.1021/acs.molpharmaceut.0c00290 ↗
84. Clinicopathological and Immunohistochemical Evaluation of Lonidamine-Entrapped Lipid–Polymer Hybrid Nanoparticles in Treatment of Benign Prostatic Hyperplasia: An Experimental Rat Model10.1016/j.ejpb.2020.10.016 ↗
85. Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma10.2147/OTT.S259428 ↗
86. Hamdi, M., Abdel-Bar, H.M., Elmowafy, E., Al-Jamal, K.T., and Awad, G.A.S. (2020). An Integrated Vitamin E-Coated Polymer Hybrid Nanoplatform: A Lucrative Option for an Enhanced in Vitro Macrophage Retention for an Anti-Hepatitis B Therapeutic Prospect. PLoS ONE, 15.10.1371/journal.pone.0227231 ↗
87. Co-Administration of Zinc Phthalocyanine and Quercetin via Hybrid Nanoparticles for Augmented Photodynamic Therapy10.1016/j.nano.2021.102368 ↗
88. Docetaxel-Loaded Lipid-Polymer Hybrid Nanoparticles for Breast Cancer Therapeutics10.1016/j.jddst.2019.03.039 ↗
89. Polymer-Lipid Hybrid Nanoparticles: A Novel Drug Delivery System for Enhancing the Activity of Psoralen against Breast Cancer10.1016/j.ijpharm.2019.03.006 ↗
90. Development and Characterization of Gemcitabine Hydrochloride Loaded Lipid Polymer Hybrid Nanoparticles (LPHNs) Using Central Composite Design10.1016/j.ijpharm.2018.06.063 ↗
91. Mitomycin C-Soybean Phosphatidylcholine Complex-Loaded Self-Assembled PEG-Lipid-PLA Hybrid Nanoparticles for Targeted Drug Delivery and Dual-Controlled Drug Release10.1021/mp500254j ↗
92. Methotrexate and Beta-Carotene Loaded-Lipid Polymer Hybrid Nanoparticles: A Preclinical Study for Breast Cancer10.2217/nnm-2017-0011 ↗
93. Ayad, C., Libeau, P., Lacroix-Gimon, C., Ladavière, C., and Verrier, B. (2021). LipoParticles: Lipid-Coated PLA Nanoparticles Enhanced In Vitro MRNA Transfection Compared to Liposomes. Pharmaceutics, 13.10.3390/pharmaceutics13030377 ↗
94. Functionalized Lipid–Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes10.1021/acs.molpharmaceut.6b01148 ↗
95. Non-Small Cell Lung Cancer Combination Therapy: Hyaluronic Acid Modified, Epidermal Growth Factor Receptor Targeted, PH Sensitive Lipid-Polymer Hybrid Nanoparticles for the Delivery of Erlotinib plus Bevacizumab10.1016/j.biopha.2020.109861 ↗
96. Chemo-Immune Synergetic Therapy of Esophageal Carcinoma: Trastuzumab Modified, Cisplatin and Fluorouracil Co-Delivered Lipid-Polymer Hybrid Nanoparticles10.1080/10717544.2020.1837294 ↗
97. An Efficient and Long-Acting Local Anesthetic: Ropivacaine-Loaded Lipid-Polymer Hybrid Nanoparticles for the Control of Pain10.2147/IJN.S190164 ↗
98. Formulation Development of Lipid Polymer Hybrid Nanoparticles of Doxorubicin and Its In-Vitro, in-Vivo and Computational Evaluation10.3389/fphar.2023.1025013 ↗
99. Sorafenib-Loaded Ligand-Functionalized Polymer-Lipid Hybrid Nanoparticles for Enhanced Therapeutic Effect Against Liver Cancer10.1166/jnn.2019.16936 ↗
100. Lipid-Chitosan Hybrid Nanoparticles for Controlled Delivery of Cisplatin10.1080/10717544.2019.1642420 ↗